The vitrification of the antiferroelectric hexatic smectic XA* phase and cold crystallization are reported for (S)-4′-(1-methylheptylcarbonyl)biphenyl-4-yl 4-[5-(2,2,3,3,4,4,4-heptafluorobutoxy) heptyl-1-oxy]benzoate. The kinetics of isothermal cold crystallization and melt crystallization are investigated, revealing that both are controlled mainly by diffusion, as indicated by decrease in the characteristic crystallization time with increasing temperature of crystallization, with an activation energy of 114 kJ/mol. A weak relaxation process is detected in a crystal phase, with an activation energy of 38 kJ/mol, implying the conformationally disordered crystal phase. The estimated fragility parameter of the investigated glass former is equal to 94.5, which indicates rather high fragility.